Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy

被引：0
|
作者：
Mazeron, MC [1 ]
Fillet, AM
Salmon, D
Boukli, N
Houhou, N
Sénéchal, B
Matheron, S
Gozlan, J
Leport, C
Katlama, C
Scieux, C
Imbert, BM
Deny, P
Bour, JB
Freymuth, F
Chanzy, B
Chaput, S
Costagliola, D
机构：
[1] Hop Lariboisiere, Dept Virol, F-75475 Paris, France
[2] Hop La Pitie Salpetriere, CERVI, Dept Virol, Paris, France
[3] Hop St Antoine, Dept Virol, F-75571 Paris, France
[4] Hop Bichat Claude Bernard, Dept Virol, F-75877 Paris, France
[5] Hop St Louis, Dept Virol, Paris, France
[6] Hop Hotel Dieu, Dept Virol, Nantes, France
[7] Hop Avicenne, Dept Virol, F-93009 Bobigny, France
[8] Hop Boccage, Dept Virol, Dijon, France
[9] Hop G Clemenceau, Dept Virol, Caen, France
[10] Hop Michallon, Dept Virol, Grenoble, France
[11] Hop Cochin, Dept Med, F-75674 Paris, France
[12] Hop Bichat Claude Bernard, Dept Infect Dis, F-75877 Paris, France
[13] Hop La Pitie Salpetriere, Dept Infect Dis, Paris, France
[14] INSERM, EMI 0214, Dept Biostat, Paris, France
来源：
AIDS | 2003年 / 17卷 / 05期
关键词：
D O I：
10.1097/00002030-200303280-00029
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页码：784 / 786
页数：3
相关论文
共 50 条
  • [1] Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy
    Jouan, M
    Savès, M
    Tubiana, R
    Carcelain, G
    Cassoux, N
    Aubron-Olivier, C
    Fillet, AM
    Nciri, M
    Sénéchal, B
    Chêne, G
    Tural, C
    Lasry, S
    Autran, B
    Katlama, C
    AIDS, 2001, 15 (01) : 23 - 31
  • [2] Anemia in HIV-infected patients receiving highly active antiretroviral therapy
    Moore, RD
    Forney, D
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (01) : 54 - 57
  • [3] Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy
    Deayton, JR
    Sabin, CA
    Johnson, MA
    Emery, VC
    Wilson, P
    Griffiths, PD
    LANCET, 2004, 363 (9427): : 2116 - 2121
  • [4] Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy
    Doan, S
    Cochereau, I
    Guvenisik, N
    Diraison, MC
    Mousalatti, H
    Hoang-Xuan, T
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 128 (02) : 250 - 251
  • [5] Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
    Sheng, Wang-Huei
    Kao, Jia-Horng
    Chen, Pei-Jer
    Huang, Li-Ming
    Chang, Sui-Yuan
    Sun, Hsin-Yun
    Hung, Chien-Ching
    Chen, Mao-Yuan
    Chang, Shan-Chwen
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (09) : 1221 - 1229
  • [6] Body composition in HIV-infected patients receiving highly active antiretroviral therapy
    Chitu-Tisu, Cristina Emilia
    Barbu, Ecaterina Constanta
    Lazar, Mihai
    Bojinca, Mihai
    Tudor, Ana-Maria
    Hristea, Adriana
    Abagiu, Adrian Octavian
    Ion, Daniela Adriana
    Badarau, Anca Ioana
    ACTA CLINICA BELGICA, 2017, 72 (01) : 55 - 62
  • [7] Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy
    Sevastianova, K
    Sutinen, J
    Westerbacka, J
    Ristola, M
    Yki-Järvinen, H
    ANTIVIRAL THERAPY, 2005, 10 (08) : 925 - 935
  • [8] Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy
    Molia, AC
    Strady, C
    Rouger, C
    Beguinot, IM
    Berger, JL
    Trenque, TC
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) : 2050 - 2054
  • [9] Subdinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy
    Calza, L
    Manfredi, R
    Chiodo, F
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (03) : 361 - 363
  • [10] Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy
    Risa, KJ
    Nepon, L
    Justis, JC
    Panwalker, A
    Berman, SM
    Cinti, S
    Wagener, MM
    Singh, N
    INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (10) : 706 - 713
12345